Abstract

This study was designed to elucidate the possible role of hOPV in the modulation of cell growth and apoptosis in cancer cell lines including human epidermoid carcinoma (HEp-2), lung epithelial cell line (A549), and breast cancer cell line (MCF-7). The oncolytic activity of hOPV on cancer cells was studiedin vitro. The virus titersweredeterminedbytissue culture infectious dose (TCID50/mL) in A549cell. The cytotoxic effect of the virus onHEp-2, A549, and MCF-7was determined using MTT and trypan blue dyeexclusion test assays. hOPV in the infected cells was detected using real-time reverse transcription polymerase chain reaction(rRT-PCR) and indirect immunofluorescence (IIF) assays. Therelative expression of apoptosis-related genes (CASP-3, -8, -9, Bax, Bcl-2, Bcl-XL, TP53, P21) during virus infection was estimated using rRT-PCR assay in comparison with the house-keeping gene (GAPDH). hOPV infection inhibited the growth of HEp-2, A549, and MCF-7cells in a dose-and time-dependent manner. At a multiplicity of infection (MOI) of 5, hOPV reduced the viability of A549cells to about 16%, HEp-2to 22%, and MCF-7to 28% (p = 0.001), while no significant inhibitory effect was observed when cells were infected at MOI of 1and 2. hOPV mRNA and antigens were detected in infected HEp-2, A549, and MCF-7cells by RT-PCR and IIF. Upon hOPV infection, expression of CASP-3, -8, -9, as well as Bax, TP53, and p21mRNA increased while expression of Bcl-2, Bcl-xL anti-apoptotic genes decreased. In hOPV-infected A549cells, the fold increase of CASP-8and CASP-9, Bax, TP53, and P21expression exceeded significantly compared to that in HEp-2or MCF-7cells. Ourresults provide evidence that hOPV could be a potential candidate for oncolytic virotherapy.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call